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Abstract
Introduction: This study established the psychometric properties and preliminary
validity of the Stricker Learning Span (SLS), a novel computer adaptive word list mem-
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ory test designed for remote assessment and optimized for smartphone use.
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Methods: Women enrolled in the Mayo Clinic Specialized Center of Research Excel-
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lence (SCORE) were recruited via e-mail or phone to complete two remote cognitive
testing sessions. Convergent validity was assessed through correlation with previously
administered in-person neuropsychological tests (n = 96, ages 55–79) and criterion
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validity through associations with magnetic resonance imaging measures of neurode-
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Results: SLS performance significantly correlated with the Auditory Verbal Learn-
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generation sensitive to Alzheimer’s disease (n = 47).
ing Test and measures of neurodegeneration (temporal meta-regions of interest and
entorhinal cortical thickness, adjusting for age and education). Test–retest reliabilities across two sessions were 0.71–0.76 (two-way mixed intraclass correlation coefficients).
Discussion: The SLS is a valid and reliable self-administered memory test that shows
promise for remote assessment of aging and neurodegenerative disorders.
KEYWORDS
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INTRODUCTION
HIGHLIGHTS

Remote cognitive assessment has transitioned from an important
research goal1 to an immediate research and clinical need due to
COVID-19. This need has underscored the lack of well-validated, reliable, and well-normed tests available for remote assessment.2 This
gap in reliable remote neuropsychological assessment tools available for research and clinical use is a barrier to assessing cognitive impairment in various research populations and for patients
without easy access to medical centers. We have developed a webbased Mayo Clinic Cognitive Testing Platform through implementation of a new

agile-inspired3

model of test development, Mayo Test

Drive (MTD): Test Development through Rapid Iteration, Validation
and Expansion (DRIVE). The MTD platform is optimized for remote,

∙ Mayo Test Drive is a new web-based platform optimized
for unsupervised test administration.
∙ Stricker Learning Span (SLS) is a computer adaptive word
list memory test for Alzheimer’s disease.
∙ The SLS and Symbols Test show adequate psychometric
properties and test–retest reliability.
∙ The SLS and Symbols Test show convergent validity
through correlations with in-person tests.
∙ The SLS shows criterion validity through significant associations with entorhinal and temporal lobe cortical thickness.

unsupervised self-administration and smartphone use, although participants can use any device with web access. Remote assessment
via smartphone is necessary to reach the most users and eliminate
potential health disparities. Rates of smartphone ownership are equal
across Blacks, Hispanics, and Whites, and individuals with lower lev-

RESEARCH IN CONTEXT

els of education and income are more likely to be smartphone-only
1. Systematic Review: Authors reviewed the literature

internet users.4–6
Identification and monitoring of early cognitive decline due to
Alzheimer’s disease (AD) is an important priority for the field. To help
address the critical need for a sensitive and brief remote memory measure, we developed a computer adaptive word list learning test to
detect the early changes in learning in preclinical and prodromal AD,7,8
the Stricker Learning Span (SLS). We transformed the traditional verbal word list memory test paradigm in several ways, resulting in a novel
supra-span learning and memory paradigm that takes full advantage of
computer-based administration. The SLS uses computer adaptive testing principles that alter the difficulty of the test to match participant
performance to extend the floor and ceiling. In addition, we included
an open-source measure of processing speed, the Symbols

Test.9

Pro-

cessing speed measures are routinely incorporated in composite cognitive measures designed to detect early preclinical changes due to their
known sensitivity to cognitive aging, AD, and other neurodegenerative
disorders.10
The aims of this study were to (1) demonstrate the feasibility of
remote self-administered cognitive measures (SLS, Symbols Test) completed via our new web-based MTD platform; (2) determine the psychometric properties of these measures, including test–retest reliabil-

involving digital and remote cognitive assessment including validation and reliability studies. We also incorporated literature investigating cognitive changes in preclinical Alzheimer’s disease (AD). While numerous publications have examined tele-neuropsychology and digital
tests, our work is the first to present data on the Stricker
Learning Span (SLS) and the Mayo Test Drive platform.
We provide additional data for the Symbols Test.
2. Interpretation: The SLS is a valid and reliable digital memory test that is associated with temporal lobe biomarkers
of neurodegeneration in older women without dementia. Mayo Test Drive is a feasible platform for collecting self-administered remote cognitive testing data via
smartphone, tablet, or personal computer.
3. Future Directions: Future work is needed to examine
the diagnostic accuracy of the SLS and Symbols Test in
patients diagnosed with mild cognitive impairment and
dementia, examine associations with AD positron emission tomography imaging biomarkers, and generate normative data.

ity; and (3) establish their preliminary convergent and criterion validity based on associations with traditional in-person neuropsychological
measures and magnetic resonance imaging (MRI) measures sensitive to
early neurodegenerative changes in AD.

ments of physical and cognitive function, and a subset participate in
neuroimaging studies.
SCORE participants who agreed to be contacted for additional stud-

2

METHOD

ies were invited to participate in this remote, web-based substudy.
Recruitment procedures involved a combination of e-mails via RED-

Participants were recruited from the Specialized Center of Research

Cap and phone calls. No remuneration was provided. Access to a smart-

Excellence (SCORE) on Sex Differences study that enrolls women

phone, tablet, or personal computer with internet connection was

aged 55 years and older who can read and speak English and pro-

required. A retest e-mail request was sent 1 week after completion

vide informed consent. SCORE participants undergo in-person assess-

of a first session, with reminder e-mails or phone calls provided as
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F I G U R E 1 Example Mayo Test Drive screen shots. Note: Mayo Test Drive subtest screen shots are depicted here on a smartphone. A, Stricker
Learning Span (SLS) is a computer adaptive word list memory test. Practice item SLS stimuli are displayed. Copyright © 2020 Mayo Foundation for
Medical Education and Research. Used with permission from Mayo Foundation for Medical Education and Research, all rights reserved. B, Symbols
Test is a processing speed measure. Copyright © 2017 Washington University in St. Louis. Used with permission from J. Hassenstab
needed. The study protocol was approved by the Mayo Clinic Institu-

domization of words (target vs. foil in each bin) occurs at each test-

tional Review Board. All participants provided informed consent.

ing session to provide endless alternative forms and reduce practice
effects. Bin order is randomized for each trial to increase difficulty and
reduce recency effects, and the last item presented is never the first

2.1

Stricker Learning Span

tested.
The primary outcome variable is the maximum learning span,

Words are visually presented to facilitate reliable self-administration

defined as the maximum number of words correctly identified on any

and ensure consistency across device types. Item memory after each

learning trial (max span, range 0–23). Secondary outcome measures

learning trial is tested via four-choice recognition (see Figure 1). Par-

include learning total correct (trials 1–5 correct, range 0–85), delay

ticipants receive a one-word practice item to ensure comprehension of

(range 0–23), and sum of trials (trials 1–5 + delay; range 0–108). Use

task instructions. If incorrect across three practice trial attempts, the

of a composite score was also explored by creating a z-score using the

SLS is discontinued. The first learning trial consists of eight words to

mean (standard deviation [SD]) of all session 1 data for max span, 1–5

remember. Words are presented sequentially for 1 second on, 1 sec-

total and delay, then averaging across these three z-scores. Not all par-

ond off. Following a computer adaptive testing approach, the number

ticipants had the opportunity to complete the delay trial because the

of words presented on each subsequent learning trial stays the same,

delay was added mid-study following our planned iterative approach to

increases, or decreases based on percentage of correct responses.11

test development. We initially hypothesized that the max span would

This computer adaptive testing method helps to determine the maxi-

correlate well with traditional measures of delayed memory; however,

mum “learning span” over five trials. High performers will be exposed

correlations were lower than expected between max span and Audi-

to up to 23 words, whereas low performers will be shown a decreasing

tory Verbal Learning Test (AVLT) delayed recall in our initial subset of

number of words across learning trials (floor = 2 items presented).

participants (Pearson r = 0.17, n = 23). Thus, we added a delay trial

The SLS uses an item bank of 92 high-frequency words extracted
from SUBTLEXUS

corpus,12

as common words are easier to recall

but harder to recognize.13 Four-word item bins were matched based

after the Symbols Test on January 17, 2021. The maximum items presented during any learning trial are tested at delay (mean delay = 3.7
minutes).

on word characteristics (imageability, length, semantic category, syllables), with a range of difficulty based on imageability ratings.14
Subsequent word bins have successively declining imageability rat-

2.2

Symbols Test

ings, increasing the difficulty level to raise the ceiling. We predict
this will increase sensitivity to early changes in preclinical AD or

The Symbols Test is an open-source measure of processing speed with

other disorders with subtle impact on memory performance. Ran-

previously demonstrated validity and reliability.9 This measure was
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developed by Jason Hassenstab, Ph.D., and is part of the Ambulatory
Research and Cognition app

(ARC).15

TA B L E 1

For each trial, participants iden-

tify which of two symbol pairs on the bottom of the screen matches one
of three symbol pairs presented at the top of the screen. The original
version used in ARC studies includes up to 28 brief 12-item trials taken
over the course of 7 consecutive days. In this shortened version, the primary outcome variable is average correct item response time (correct
RT, sec) across four 12-item trials. Secondary outcome variables were
also explored (see Tables for definitions).

2.3

Participant characteristics for session 1 (n = 96)
Mean (SD)

Median

Range

Age at in-person visit, years

66.0 (5.4)

65.0

55–79

Age at remote MTD session
1, years

66.5 (5.4)

65.8

55–79

Education, years

14.9 (2.2)

14.0

12–19

3MS, raw

96.2 (3.8)

98.0

83–100

Months since in-person
testing for MTD

10.1 (6.8)

7.9

0.5–23.8

Race (% White)

92.7%a

–

–

Ethnicity (% Non-Hispanic)

90.6%b

–

–

In-person neuropsychological measures

A neuropsychological test battery was administered by a psychometrist under the supervision of a board-certified neuropsychologist

Abbreviations: 3MS, Modified Mini-Mental State Examination; MTD, Mayo
Test Drive; SD, standard deviation.
a
n = 89 White, n = 1 African American, n = 2 Asian, n = 4 unknown.
b
n = 87 Non-Hispanic, n = 2 choose not to disclose, n = 7 unknown.

(JAF). We examined validity of the SLS using AVLT sum of trials16
as the primary outcome (secondary outcomes included trial 5, trials
1–5, 30-minute delay, and recognition percent correct), and Symbols
Test using processing speed measures including Wechsler Adult Intel-

and regression models were fit separately within men (n = 90) and
women (n = 66).

ligence Scale-Revised Digit Symbol Coding (Coding) and Trail Making
Test (Trails A & B). Raw scores were used for all analyses.

2.5

Statistical methods

We report Pearson bivariate correlation coefficients to assess con-

2.4

Magnetic resonance imaging measures

vergent validity with in-person neuropsychological measures. Test–
retest reliability is determined by computing single-rating, absolute-

Brain MRI was conducted on 3T scanners (Prisma, Siemens) with a

agreement, two-way mixed intraclass correlations (ICCs) with 95%

3D magnetization prepared rapid acquisition gradient-echo (MPRAGE)

confidence intervals (CIs) around the ICCs.22 ICCs are interpreted

sequence. These were tissue-class segmented using Unified Segmen-

using recommended ranges.23 Randomized alternate forms are used

tation

17

in SPM12 with population-optimized priors and settings

for both tests, thus reliability coefficients also represent alternate form

from the Mayo Clinic Adult Lifespan Template (MCALT) (https://www.

reliability. Practice effects were calculated by determining the paired

nitrc.org/projects/mcalt/). These segmentations were used to sum

difference of Session 1 and Session 2; Cohen’s d effect sizes were cal-

the total intracranial volume (ICV) and estimate cortical thickness

culated using pooled SDs, and significance was determined based on

using Advanced Normalizaion Tools (ANTs) diffeomorphic registration-

whether the 95% CI contained 0.

based cortical thickness (DiReCT).18,19 ANTs’ symmetric normalization

Participants completing all elements of the SLS (including delay) who

was used to warp the MCALT_ADIR122 atlas for computing regional

also had MRI data available were included in criterion validity analyses

measurements.20 We derived entorhinal cortical thickness and a tem-

with continuous MRI variables. We report Pearson partial correlation

poral meta-region of interest (ROI; previously referred to as an AD-

coefficients controlling for age and education to explore associations

signature composite ROI). The temporal meta-ROI is composed of

between neuropsychological and MRI measures. Alpha level was set to

the voxel-number weighted average cortical thickness of six tem-

0.05 for this pilot study.24

poral lobe ROIs (entorhinal cortex, fusiform, parahippocampal, midtemporal, inferior temporal, angular gyrus).19 This temporal meta-ROI
was previously derived using Youden’s index criteria to separate cog-

3

RESULTS

nitively unimpaired from clinically diagnosed and autopsy-confirmed
AD patients and tested for diagnostic reliability and accuracy; it is

3.1

Participant characteristics

sensitive to but not specific for AD.19 Hippocampal volume (HV) was
adjusted for ICV by calculating the residual from a linear regression

We included all participants who initiated a MTD session from study

of hippocampal volume (y) versus ICV (x) based on a sex-specific for-

initiation on December 9, 2020 through July 27, 2021. Of 258 women

mula (for women: HV adjusted for IVC = observed HV − (7.88 +

invited to participate in this all-remote study, 99 enrolled by our data

0.00476 × [observed ICV – 1500]). This is similar to the approach

analysis cut-off (recruitment is ongoing). Sample characteristics of

previously reported by Jack et al.21 but using SPM12, a different

enrolled and identifiable participants completing at least one complete

group of cognitively unimpaired participants ages 30 to 49 (N = 156)

MTD session (n = 96) are reported in Table 1. Modified Mini-Mental
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TA B L E 2 Test–retest reliability coefficients and magnitude of practice effects: Pearson’s rho and intraclass correlation coefficient (ICC 3,2),
n = 89 unless otherwise noted
ra

ICC

ICC 95% CI

Session 1
mean (SD)

Session 2
mean (SD)

Practice effect Cohen’s d

SLS Max Span

0.61

0.76

(0.63 0.84)

17.9 (3.4)

18.0 (3.2)

0.03 (−0.15, 0.22)

b

0.62

0.76

(0.64, 0.84)

64.6 (11.8)

65.7 (11.6)

0.09 (−0.09, 0.27)

Stricker learning span

SLS 1-5 Total

0.57

0.71

(0.54, 0.82)

16.6 (4.1)

15.8 (3.9)

−0.20 (−0.44, 0.03)

SLS Sum of Trialsd

0.61

0.74

(0.58, 0.84)

82.5 (15.9)

81.4 (15.6)

−0.07 (−0.30, 0.15)

SLS Compositee

0.61

0.74

(0.58, 0.84)

0.10 (0.98)

0.02 (0.96)

−0.08 (−0.30, 0.14)

0.72

0.83

(0.75, 0.89)

3.15 (0.78)

2.88 (0.73)

−0.36 (−0.52, −0.20)

0.76

0.86

(0.79, 0.91)

36.2 (7.9)

34.4 (7.8)

−0.22 (−0.37, −0.07)

0.73

0.84

(0.76, 0.89)

39.4 (8.8)

37.2 (8.8)

−0.25 (−0.40, −0.09)

0.72

0.83

(0.75, 0.89)

40.9 (9.3)

37.6 (8.7)

−0.37 (−0.54, −0.21)

0.72

0.84

(0.75, 0.89)

163.8 (37.4)

150.3 (34.8)

−0.37 (−0.54, −0.21)

SLS Delay

c

Symbols Test
SYM Correct RTf
SYM Best 2 Average

g

SYM Middle 2 Averageh
SYM All 4 Average

i

SYM All 4 Total Secondsj

Abbreviations: CI, confidence interval; SD, standard deviation; SLS, Stricker Learning Span; SLS Max Span, maximum number of words recognized across any
learning trial; SLS 1–5 Total, sum of words correctly recognized across trials 1–5; SLS Sum of Trials, SLS 1–5 total + delay; SLS Composite, mean z-score (SLS
max span, SLS 1–5 total, SLS delay); SYM, Symbols Test; SYM Correct RT, average response time per item (correct trials only) across all four trials; SYM Best
2 Avg, seconds to complete a trial averaged across the two trials with the fastest completion times; SYM Middle 2 Avg, seconds to complete a trial averaged
across two trials, excluding highest and lowest performances; SYM All 4 Avg, seconds to complete a trial averaged across all four trials.
Randomized alternate forms are used for both tests thus reliability coefficients also represent alternate form reliability.
a
All correlation coefficients were significant (P < 0.001).
b
n = 88.
c
n = 61 due to addition of delay after start of study.
d
1–5 total + delay, n = 61.
e
Mean z-score (max span, 1–5 total, delay), n = 61.
f
Average response time per item (correct trials only) across all four trials, seconds.
g
Seconds to complete a trial averaged across the two trials with the fastest completion times.
h
Seconds to complete a trial averaged across two trials, excluding highest and lowest performances.
i
Seconds to complete a trial averaged across all four trials.
j
Seconds to complete all four trials (summative).

State Examination (3MS) scores were all above recommended cut-offs

to request assistance. Technological problems reported by participants

for dementia (>78).25 Mean performance on traditional in-person neu-

who replied to study e-mails were focused on difficulties with some e-

ropsychological measures were within the average range based on nor-

mails coming through without any text in the body of the email, related

mative scores (Table S1 in supporting information).26,27

to issues with REDCap.

3.2

3.2.3

3.2.1

Feasibility of remote measures
User/session factors

Efficiency

Median time to complete the first test session was 15.1 minutes (Table
S2; subtest completion times are also provided).

Participants completed MTD across a variety of device types including
smartphones (50%), tablets (3%), and computers (47%); see Table S2
in supporting information. A minority endorsed the presence of noise

3.3

Psychometric properties

during testing (4%) or interference during a subtest (4%–12%). Many
participants (51%) provided comments at the end of the session.

3.3.1

Reliability

Test–retest reliability across two sessions for SLS learning variables

3.2.2

Acceptability/completion rates

were good (at or above 0.75 ICC; see Table 2); delay was slightly lower
(0.71, adequate). All test–retest reliability coefficients for Symbols Test

Ninety-eight percent of participants completed a test session upon ini-

were good and all exceeded 0.83 ICC, with subtly higher reliability

tiating the first session (Table S2). No one called the study coordinator

noted when using average seconds for the best two out of four trials
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TA B L E 3 Pearson correlation coefficients between session 1 Mayo Test Drive measures and in-person neuropsychological tests (n = 96 unless
otherwise noted)

AVLT Trial 5

SLS Max
Span

SLS 1-5
Total

SLS
Delaya

SLS Sum
of Trialsa

0.45***

0.44***

0.42***

0.42***

−0.16

0.30

−0.17

−0.12

−0.18

−0.19

0.30

**

−0.09

−0.07

−0.08

−0.10

0.32**

0.35***

0.35**

0.33**

0.33**

−0.17

−0.13

−0.17

−0.18

AVLT Recogn
PC

0.43***

0.48***

0.51***

0.49***

0.49***

−0.07

−0.05

−0.08

−0.09

−0.22*

Digit symbol
coding

0.24

*

−0.24*
0.29

**

−0.07

−0.26*
0.27

0.30

*

−0.17

0.26

−0.11

0.31

−0.10

AVLT Sum of
Trials

Trails B

0.36

**

−0.15

*

0.42***

AVLT Delay

−0.08

0.29

SYM
All 4
Avgb

*

−0.07

0.27

**

*

SYM
Middle 2
Avg

0.30

Trails A

0.33

*

SLS c

SYM Best
2 Avg

**

AVLT 1–5 Total

***

SYM
correct RT

*

−0.08

−0.22
0.25

−0.22
*

0.25

*

0.40***

0.43***

0.44***

0.40***

0.44***

0.42***

0.43***

0.44***

−0.49

***

−0.48

***

−0.50

***

−0.49***

Abbreviations: AVLT, Auditory Verbal Learning Test; AVLT Sum of Trials, AVLT 1–5 total + Trial 6 + 30-min delay; AVLT Recogn PC, Recognition Percent
Correct = {[recognition hits+(15 – recognition false positive errors)]/30} × 100; SLS, Stricker Learning Span; SLS Max Span, maximum number of words recognized across any learning trial; SLS 1–5 Total, sum of words correctly recognized across trials 1–5; SLS Sum of Trials, SLS 1–5 total + delay; SLS Composite,
mean z-score (SLS max span, SLS 1–5 total, SLS delay); SYM, Symbols Test; SYM Correct RT, average response time per item (correct trials only) across all four
trials; SYM Best 2 Avg, seconds to complete a trial averaged across the two trials with the fastest completion times; SYM Middle 2 Avg, seconds to complete
a trial averaged across two trials, excluding highest and lowest performances; SYM All 4 avg, seconds to complete a trial averaged across all four trials.
a
n = 68 due to addition of delay after start of study.
b
Correlations for Symbols all four total seconds are identical to those of Symbols all 4 sec, average.
*P < 0.05.
**P < 0.01.
***P < 0.001.

(0.86 ICC). Median days between the two sessions was 13.0 (mean

3.4

Validity

18.6, range 7–85).

3.4.1
3.3.2

Practice effects

Associations with demographic variables

Age correlations with SLS (–0.05 to –0.24) were larger in magnitude
than age correlations with AVLT (0.00 to –0.12; Table S3 in support-

No SLS measures showed significant practice effect (CI included 0; see

ing information). Education correlations with SLS (0.04–0.13) were

Table 2). SLS delay showed evidence for a small but non-significant

similar to AVLT education correlations (0.01–0.16). Age correlations

decrease in performance at session 2 (d = –0.20). All Symbols Test vari-

with Symbols (0.34–0.36) were similar to age correlations with Cod-

ables showed a small practice effect, with significantly faster perfor-

ing (–0.34). Education correlations with Symbols (–0.03 to –0.07) were

mance at session 2.

smaller in magnitude than Coding (0.15).

3.3.3

3.4.2
Associations with in-person
neuropsychological tests

Distributional properties

Distributional properties of SLS variables were similar to in-person
administered AVLT recall measures (Table S1). No participant showed

SLS showed significant correlations with AVLT variables (Table 3); cor-

a floor effect on the SLS. Ceiling effects for the SLS (4% max span, 3%

relations with AVLT Trial 5 recall and AVLT Recognition PC were high-

delay) were infrequent and similar to AVLT recall (7% Trial 5, 2% delay).

est (0.42–0.51). SLS and AVLT delay (0.36) and sum of trials (0.33)

Use of four-choice recognition provided better distributional proper-

showed moderate relationships. SLS also showed significant correla-

ties relative to the prominent ceiling effect observed for AVLT recogni-

tions with Coding (0.24–0.29) and Trails B (–0.22 to –0.26), but not

tion (23% AVLT recognition percent correct; 39% hits). Distributional

Trails A; AVLT showed the same pattern of associations with these mea-

properties of Symbols Test time-based variables were similar to Trails

sures (Table 3 and Tables S4 and S5 in supporting information). Symbols

A and were less skewed than Trails B raw scores but less normally dis-

showed significant correlations with Coding (–0.48 to –0.49), Trails A

tributed than Coding.

(0.40–0.43), and Trails B (0.42–0.44).
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TA B L E 4 Partial correlation coefficients, adjusted for age and
education (n = 47)
Temporal
meta-ROI Entorhinal
cortex
cortical
thickness thickness

4

DISCUSSION

This study examines feasibility, psychometric properties, and converHippocampal
volume,
ICV adj.

Mayo Test Drive (remote)

gent validity of web-based, self-administered neuropsychological tests
using the MTD platform. In addition, we examine criterion validity
through associations with biomarkers of neurodegeneration sensitive
to AD.

SLS Max Span

0.30*

0.33*

0.22

Consistent with our flexible platform, participants used a variety of

SLS 1–5 Total

0.34*

0.30*

0.14

devices to complete the tests in approximately 15 minutes. Although

SLS Delay

0.22

0.25

0.15

we specifically encouraged use of smartphones, only half of partici-

SLS Sum of Trials

0.32*

0.29

0.14

pants chose to use a smartphone; 47% used personal computers and

0.16

3% tablets. Once a session was initiated, most participants (98%) completed the full first session, suggesting acceptability of the platform

*

*

SLS Composite

0.31

SYM Correct RT

0.02

−0.11

−0.10

SYM Best 2 Average

0.01

−0.16

−0.11

SYM Middle 2 Average

0.02

−0.13

−0.11

SYM All 4 Avga

0.01

−0.12

−0.07

0.03

0.17

0.03

tered orally via telephone, videoconferencing, or automated record-

AVLT Trial 5

−0.17

0.05

−0.04

ings, such as misinterpretation of words spoken due to hearing prob-

AVLT Delay

−0.02

0.26

−0.06

lems or suboptimal audio quality.28,29 Though infrequent, we were able

AVLT Sum of Trials

0.01

0.21

0.01

to capture reports of environmental interference and participant com-

AVLT Recogn % Correct

0.14

0.24

0.03

−0.16

0.10

−0.11

Trails A

0.04

−0.14

0.12

Trails B

−0.07

−0.17

0.01

0.30

In-person measures
AVLT 1–5 Total

Digit Symbol Coding

and subtests. We predict that participants’ technological literacy with
their own specific and preferred devices will translate to high feasibility in other populations as well. The self-administered web-based
design relying on visual presentation of stimuli eliminates other potential confounds that may occur when list-learning tests are adminis-

Note: AVLT, Auditory Verbal Learning Test; AVLT Sum of Trials, AVLT 1-5
total + Trial 6 + 30-min delay; AVLT Recogn PC, Recognition Percent Correct = {[recognition hits+(15 – recognition false positive errors)]/30} × 100;
ICV, intercranial volume; ROI, region of interest; SLS, Stricker Learning
Span; SLS Max Span, maximum number of words recognized across any
learning trial; SLS 1–5 Total, sum of words correctly recognized across trials
1–5; SLS Sum of Trials, SLS 1–5 total + delay; SLS Composite, mean z-score
(SLS max span, SLS 1-5 total, SLS delay); SYM, Symbols Test; SYM Correct
RT, average response time per item (correct trials only) across all four trials;
SYM Best 2 Avg, seconds to complete a trial averaged across the two trials
with the fastest completion times; SYM Middle 2 Avg, seconds to complete
a trial averaged across 2 trials, excluding highest and lowest performances;
SYM All 4 avg, seconds to complete a trial averaged across all four trials.
a
Correlations for Symbols all four total seconds are identical to those of
Symbols all 4 sec, average.
*P < 0.05.

ments that may impact interpretation of session results. We have previously observed lower performance on other self-administered cognitive measures at home versus in clinic.30 Madero et al.31 similarly
reported the presence of distraction in a minority of remote cognitive assessment sessions (7%), which had a negative impact on performance. Future work will examine whether participant self-report
of interference can help reduce variability introduced by testing in an
unsupervised environment.
Overall, the psychometric properties of the SLS and Symbols
Test are comparable to neuropsychological tests administered in
person. For example, they exhibit test–retest reliability over two
time points comparable to traditional paper-and-pencil measures;32
person-administered and self-administered supervised computerized
tests;33–36 as well as other novel self-administered, unsupervised
memory test paradigms.37 No practice effects were observed on the
SLS, consistent with prior work showing that use of alternate forms
reduces the magnitude of practice effects.38 With larger samples, we
expect a small practice effect over time may be observed, as we have
reported small practice effects on other measures that use randomized
alternate forms.30 Interestingly, we saw an unexpected decline in performance on SLS delay at session 2 that was non-significant and small

3.4.3

Association with MRI measures

in magnitude (Cohen’s d = 0.20). We use the same word bins to generate the randomized alternate form for each session, thus for each word

Most SLS variables showed significant correlations with temporal

bin the same four choices are displayed at test; only the target word

meta-ROI and entorhinal cortex thickness (0.29–0.34; Table 4); the cor-

to be remembered is randomized. It is possible that proactive interfer-

relation for SLS delay was not significant (0.22–0.25). SLS correlations

ence from session 1 target words could have impacted performance at

with hippocampal volume also did not reach significance (0.14–0.22).

session 2.39 Longer durations between sessions may potentially reduce

No AVLT variables showed significant correlations with MRI measures

this interference. All Symbols Test variables showed a small practice

(0.03–0.26). Symbols, Trails A, and Trails B did not show significant cor-

effect, with faster performance at session 2. Using the best two trials

relations with these MRI measures (–0.17 to 0.12).

of four decreased the magnitude of this practice effect and increased
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F I G U R E 2 Example learning slopes for the Auditory Verbal Learning Test (AVLT) and the Stricker Learning Span (SLS). Note: Data from two
participants were selected to display example high and low performers on the SLS. The high performer (blue dashed line) showed high average
learning performance on the AVLT (AVLT trials 1–5 total = 55, normative score of 57 T). The low performer (black solid line) showed mildly to
moderately impaired learning performance on the AVLT (AVLT 1–5 total = 28, normative score of 28 T). These same two individuals showed a
similar pattern of performance across SLS learning trials (panel B). The high performer (blue dashed line) showed a strongly positive learning slope
over the 5 learning trials (SLS 1–5 total = 67), and a max span of 21. The greater slope increase seen on trials 3–5 on the SLS relative to the AVLT
may indicate that our adaptive testing format is successfully raising the ceiling for this high performer. The low performer (black solid line) showed
a comparatively flat learning slope (SLS 1–5 total = 34), and a max span of 8
reliability slightly. Future work with larger samples will help determine

ume. While measures of hippocampal volume are often associated with

the potential influence of external factors on reliability including device

memory performance, these findings are frequently reported in sam-

(e.g., type, consistent vs. different device)40 and reported interruptions

ples of participants with MCI8,44 or AD dementia,45 and often are not

to guide robust data analysis, normative data development, and clinical

significant in participants with normal cognition.46 In addition, Wolk

interpretation. Finally, distributional properties of MTD subtests were

and Dickerson45 showed that while the hippocampus correlated with

similar to in-person–administered measures of similar constructs.

AVLT delayed recall in a mild AD sample, perirhinal/entorhinal cor-

The SLS is a novel test designed to be sensitive to changes in

tex thickness correlated more strongly with recognition discrimina-

memory encoding by expanding upon existing list-learning paradigms.

tion than did the hippocampus. Similarly, Yonelinas et al.47 reported

Typical recognition formats (yes/no response to test items and dis-

that age-related decreases in hippocampal volume are associated with

tractor items) are less sensitive to mild cognitive impairment (MCI)

decreases in recall, whereas entorhinal volume reductions are associ-

and AD dementia than spontaneous verbal free recall.41 In contrast,

ated with decreased recognition. These prior findings help explain why

when a more challenging 4-choice recognition format is used, recog-

the SLS, with its recognition-based testing format, is showing signifi-

nition paradigms can show sensitivity to AD dementia that is com-

cant associations with entorhinal cortical thickness, but not hippocam-

parable to free recall.42 The current study suggests that our com-

pal volume. Future work is needed to see what regions within the tem-

puter adaptive and 4-choice recognition approach is simulating recall

poral meta-ROI may be driving associations, and voxel-wise analyses

as designed, demonstrated by significant correlations between AVLT

would be a helpful complement to the current ROI-focused approach.

and SLS variables, and illustrated by example learning curves for high

There are limitations to acknowledge. First, our sample is all female

and low performers (Figure 2). We predict the SLS will have a lower

and representative of the local demographics. Initial data collection

floor than recall-based memory measures in individuals with cogni-

in the Mayo Clinic Study of Aging is underway and will provide the

tive impairment. The Symbols Test also showed significant correlations

broader and larger sample needed for further examination of psycho-

with person-administered measures of processing speed.

metric properties, validation, and normative data development, though

Structural neuroimaging markers of neurodegeneration, including

additional work will be needed to validate the SLS in ethnoracial and

temporal meta-ROI and entorhinal cortical thickness, were signifi-

culturally diverse samples. Use of word frequency to guide word selec-

cantly associated with SLS performances, providing preliminary sup-

tion will help facilitate future translation of the SLS to other languages.

port for SLS criterion validity. Word list recall was associated with an

MTD was completed, on average, 10 to 11 months after in-person test-

alternative “AD-signature” cortical thickness ROI in a group of adults

ing and imaging; this time interval could decrease the effects observed

without significant psychiatric or neurological history (age range 21–

if intervening factors influenced performance. We applied a simple

78),43 thus the lack of association between AVLT and cortical thick-

cut-off based on the 3MS to determine absence of dementia in this

ness measures was somewhat unexpected. In addition, neither the

sample. Further, measures of neurodegeneration are not specific to

SLS nor AVLT showed significant associations with hippocampal vol-

AD. To establish construct validity of MTD measures, future studies

STRICKER ET AL .

are needed to examine associations with amyloid and tau biomarkers,
explain the theory underlying test development (in preparation), examine diagnostic accuracy in well-characterized clinical groups, and to
apply factor analytic methods to better establish convergent and divergent validity in a larger sample.48
There is increasing interest in developing digital tools to detect and
track preclinical and prodromal stages of AD.15 MTD helps address
several emerging needs for digital tools, including a multi-device
web-based platform that can increase representativeness of samples
through ease of access, inclusion of methods to capture the presence of
test interference in an unsupervised environment, and use of computer
adaptive and multi-trial test design to help counteract the expected
increased variability in performance with unsupervised and/or remote
assessment methods.
Our results support the feasibility of MTD and strong psychometrics properties of the SLS and Symbols Test in a sample of female older
adults. In addition, the SLS is correlated with biomarkers of neurodegeneration sensitive to AD. MTD shows potential as an equitable platform for self-administered cognitive measures to increase access for
research and clinical use.
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